Ownership history in VR Adviser, LLC · 11 quarters on record
This page tracks every 13F SEC filing in which VR Adviser, LLC reported a position in ORIC PHARMACEUTICALS INC (ORIC). Data includes quarterly share count, position size as % of portfolio, estimated market value, and end-of-quarter stock price — sourced directly from SEC EDGAR 13F filings.
| Quarter | Action | Shares | Change | Chg % | % of Fund | Mkt Value | Price (EOQ) |
|---|---|---|---|---|---|---|---|
| 2025 Q4 | REDUCED | 5,676,230 | -920,655 | -14.0% | 2.29% | $46.4M | $8.18 |
| 2025 Q3 | UNCHANGED | 6,596,885 | — | 0% | 4.46% | $79.2M | $12.00 |
| 2025 Q2 | ADDED | 6,596,885 | +3,414,358 | +107.3% | 5.02% | $67.0M | $10.15 |
| 2025 Q1 | REDUCED | 3,182,527 | -1,212,000 | -27.6% | 1.51% | $17.8M | $5.58 |
| 2024 Q4 | UNCHANGED | 4,394,527 | — | 0% | 2.43% | $35.5M | $8.07 |
| 2024 Q3 | UNCHANGED | 4,394,527 | — | 0% | 2.36% | $45.0M | $10.25 |
| 2024 Q2 | UNCHANGED | 4,394,527 | — | 0% | 1.98% | $31.1M | $7.07 |
| 2024 Q1 | ADDED | 4,394,527 | +1,966,142 | +81.0% | 2.87% | $60.4M | $13.75 |
| 2023 Q4 | ADDED | 2,428,385 | +285,529 | +13.3% | 1.53% | $22.3M | $9.20 |
| 2023 Q3 | UNCHANGED | 2,142,856 | — | 0% | 1.36% | $13.0M | $6.05 |
As of 2025 Q4 — sorted by position size